These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 20477831

  • 1. Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis.
    Dziedzic T, Metz I, Dallenga T, König FB, Müller S, Stadelmann C, Brück W.
    Brain Pathol; 2010 Sep; 20(5):976-85. PubMed ID: 20477831
    [Abstract] [Full Text] [Related]

  • 2. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S, Dallenga T, Winkler A, Roemer S, Maruschak B, Siebert H, Brück W, Stadelmann C.
    J Neuroinflammation; 2017 Mar 17; 14(1):57. PubMed ID: 28302146
    [Abstract] [Full Text] [Related]

  • 3. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.
    Singh S, Metz I, Amor S, van der Valk P, Stadelmann C, Brück W.
    Acta Neuropathol; 2013 Apr 17; 125(4):595-608. PubMed ID: 23354834
    [Abstract] [Full Text] [Related]

  • 4. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.
    Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM.
    Brain; 2000 Sep 17; 123 ( Pt 9)():1845-9. PubMed ID: 10960048
    [Abstract] [Full Text] [Related]

  • 5. Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis.
    Seehusen F, Baumgärtner W.
    Brain Pathol; 2010 May 17; 20(3):551-9. PubMed ID: 19775292
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Demyelination and axonal damage in a non-human primate model of multiple sclerosis.
    Mancardi G, Hart B, Roccatagliata L, Brok H, Giunti D, Bontrop R, Massacesi L, Capello E, Uccelli A.
    J Neurol Sci; 2001 Feb 15; 184(1):41-9. PubMed ID: 11231031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG, Hahn A.
    J Neurol Sci; 2007 Sep 15; 260(1-2):23-32. PubMed ID: 17493638
    [Abstract] [Full Text] [Related]

  • 12. Abnormal ubiquitination of axons in normally myelinated white matter in multiple sclerosis brain.
    Giordana MT, Richiardi P, Trevisan E, Boghi A, Palmucci L.
    Neuropathol Appl Neurobiol; 2002 Feb 15; 28(1):35-41. PubMed ID: 11849561
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E, Pardo LA, Gold R, Linker RA.
    Neurobiol Dis; 2008 May 15; 30(2):162-73. PubMed ID: 18342527
    [Abstract] [Full Text] [Related]

  • 15. Traumatic axonal injury in the perisomatic domain triggers ultrarapid secondary axotomy and Wallerian degeneration.
    Kelley BJ, Farkas O, Lifshitz J, Povlishock JT.
    Exp Neurol; 2006 Apr 15; 198(2):350-60. PubMed ID: 16448652
    [Abstract] [Full Text] [Related]

  • 16. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H.
    J Neurosci Res; 2008 Dec 15; 86(16):3548-55. PubMed ID: 18709652
    [Abstract] [Full Text] [Related]

  • 17. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis.
    Schirmer L, Antel JP, Brück W, Stadelmann C.
    Brain Pathol; 2011 Jul 15; 21(4):428-40. PubMed ID: 21114565
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology.
    Petzold A, Gveric D, Groves M, Schmierer K, Grant D, Chapman M, Keir G, Cuzner L, Thompson EJ.
    Exp Neurol; 2008 Oct 15; 213(2):326-35. PubMed ID: 18619438
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice.
    Coleman MP, Adalbert R, Beirowski B.
    J Neurol Sci; 2005 Jun 15; 233(1-2):133-8. PubMed ID: 15899498
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.